Federal Register / Vol. 72, No. 95 / Thursday, May 17, 2007 / Notices 27821 

3. Conduct clinical trials of 

recombinant vaccines alone and in 

combination therapies, and 

4. Provide Drug Master Files currently 

supporting the clinical use of the 

recombinant poxvirus vaccines. 

If interested in the above described 

CRADA, please submit a statement of 

interest and capability to Kevin Chang, 

PhD, in the NCI Technology Transfer 

Center at changke@mail.nih.gov or 301–

496–0477. 

Dated: May 11, 2007. 

Steven M. Ferguson, 

Director, Division of Technology Development 

and Transfer, Office of Technology Transfer, 

National Institutes of Health. 

[FR Doc. E7–9541 Filed 5–16–07; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary 

and Alternative Medicine; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; Basic Science. 

Date: June 11–12, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard Marriott, Washingtonian 

Center, 240 Boardwalk Place (Rio), 

Gaithersburg, MD 20878. 

Contact Person: Dale L. Birkle, Ph.D, 

Scientific Review Administrator, Office of 

Scientific Review, National Center for 

Complementary, and Alternative Medicine, 

NIH, 6707 Democracy Blvd., Suite 401, 

Bethesda, MD 20892, (301) 451–6570. 

birkled@mail.nih.gov. 

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; Centers of 

Excellence for Research on Complementary 

and Alternative Medicine. 

Date: June 20–22, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Martina Schmidt, Ph.D, 

Scientific Review Administrator, Office of 

Scientific Review, National Center for 

Complementary, and Alternative Medicine, 

NIH, 6707 Democracy Blvd., Suite 401, 

Bethesda, MD 20892, (301) 594–3456. 

schmidma@mail.nih.gov. 

Dated: May 8, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2427 Filed 5–16–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Eye Institute; Notice of Open 

Meeting 

The National Eye Institute will host 

an Ocular Epidemiology Program 

Planning Panel Meeting to discuss 

research needs and opportunities in 

ocular epidemiology. The meeting will 

be open to the public. 

The thoughts and input from this 

meeting will be given by the panel 

members individually and incorporated 

into a report that will be given to the 

National Eye Institute. 

Name of Panel: Ocular Epidemiology 

Panel. 

Date: May 24–25, 2007. 

Time: 8 a.m.–5 p.m. 

Agenda: To discuss the Ocular 

Epidemiology Research. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, (7400 Wisconsin 

Avenue), Bethesda, MD 20814. 

Contact Person: Mr. Michael Davis, 

Associate Director for Science Policy and 

Legislation, National Eye Institute, Bldg. 31; 

Room 6A25, 31 Center Drive MSC 2510, 

Bethesda, MD 20892, (301) 496–4308. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Any interested person may file written 

comments with the panel by forwarding the 

statement to the Contact Person listed on this 

notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.867, Vision Research, 

National Institutes of Health, HHS) 

Dated: May 8, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2425 Filed 5–16–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Eye Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Advisory Eye Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Eye Council. 

Date: June 7, 2007. 

Closed: 8:30 a.m. to 10:30 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Room D, Bethesda, MD 20892. 

Open: 10:30 a.m. to Adjournment. 

Agenda: Following opening remarks by the 

Director, NEI there will be presentations by 

the staff of the Institute and discussions 

concerning Institute programs. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Room D, Bethesda, MD 20892. 

Contact Person: Lore Anne McNicol, PhD, 

Director, Division of Extramural Research, 

National Eye Institute, National Institutes of 

Health, Bethesda, MD 20892, (301) 451–2020. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 


pwalker on PROD1PC71 with NOTICES